Strikingly, BCR-induced phosphorylation of p-PLCγ was significantly lower in the malignant B cells from SLL/CLL and MZL patients, compared to healthy donor B cells, with an 83% and 62% reduction in median MFI, respectively. Here, BCR is linked to B-cell chronic lymphocytic leukemia.